Zoetis (ZTS) Net Income Growth (3y) (2015 - 2026)

Zoetis (ZTS) Net Income Growth (3y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 51.28%
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 2.94%
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 4.50%
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 68.16%
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 66.11%
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -17.90%
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -30.70%
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 253.53%
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -109.16%
10 Liquidia 5.74 Bn 5.52 Bn 121.79 Mn 96.66%

Historic Data

Download Data
DateValue
Mar 31, 2026 2.94%
Dec 31, 2025 9.44%
Sep 30, 2025 10.94%
Jun 30, 2025 10.72%
Mar 31, 2025 0.45%
Dec 31, 2024 12.05%
Sep 30, 2024 7.83%
Jun 30, 2024 6.89%
Mar 31, 2024 2.39%
Dec 31, 2023 13.47%
Sep 30, 2023 7.56%
Jun 30, 2023 21.24%
Mar 31, 2023 3.50%
Dec 31, 2022 6.20%
Sep 30, 2022 6.84%
Jun 30, 2022 12.55%
Mar 31, 2022 23.94%
Dec 31, 2021 6.18%
Sep 30, 2021 16.74%
Jun 30, 2021 10.18%